Table 3.
Overall and breast cancer–specific survival and recurrence data for the unmatched and matched cohorts.
| Total cohort | Unmatched |
Matched |
|||
|---|---|---|---|---|---|
| PET |
Surgery |
PET |
Surgery |
||
| N = 500 | N = 2354 | N = 238 | N = 422 | ||
| Overall survival | Data available | 486 | 2307 | 229 | 414 |
| Alive | 351 (72.2%) | 2095 (90.8%) | 150 (65.5%) | 308 (74.4%) | |
| Died of any cause | 135 (27.8%) | 212 (9.2%) | 79 (34.5%) | 106 (25.6%) | |
| Cause-specific survival | Data available | 477 | 2297 | 223 | 408 |
| Alive or died of other causes | 452 (94.8%) | 2217 (96.5%) | 206 (92.4%) | 381 (93.4%) | |
| Died of breast cancer | 25 (5.2%) | 80 (3.5%) | 17 (7.6%) | 27 (6.6%) | |
| Recurrence (all types) | Data available | 451 | 2325 | 221 | 417 |
| No | 418 (92.7%) | 2212 (95.1%) | 210 (95.0%) | 392 (94.0%) | |
| Yes | 33 (7.3%) | 113 (4.9%) | 11 (5.0%) | 25 (6.0%) | |
| Metastatic recurrence | Data available | 450 | 2324 | 221 | 417 |
| No | 423 (94.0%) | 2236 (96.2%) | 211 (95.5%) | 399 (95.7%) | |
| Yes | 27 (6.0%) | 88 (3.8%) | 10 (4.5%) | 18 (4.3%) | |